Interactions of calf spleen purine nucleoside phosphorylase (PNP) with a non-typical substrate, 8-azaguanine (8-azaG), and a bisubstrate analogue inhibitor, 9-(2-phosphonylmethoxyethyl)-8-azaguanine (PME-azaG), were investigated by means of steady-state fluorescence spectroscopy. Both 8-azaG and PME-azaG form fluorescent complexes with the enzyme, and dissociation constants are comparable to the appropriate parameters (K m or K i ) obtained from kinetic measurements. PME-azaG inhibits both the phosphorolytic and synthetic pathway of the reaction in a competitive mode. The complex of 8-azaG with PNP is much weaker than the previously reported Gua-PNP complex, and its dissociation constant increases at pH > 7, where 8-azaG exists predominantly as the monoanion (pK a Ϸ 6.5). The fluorescence difference spectrum of the PNP/8-azaG complex points to participation of the N(7)H or/and N(8)H tautomers of the neutral substrate, and the 9-(2-phosphonylmethoxyethyl) derivative also exists as a neutral species in the complex with PNP. The latter conclusion is based on spectral characteristics of the PNP/PME-azaG complex, confirmed by fluorimetric determination of dissociation constants, which are virtually pH-independent in the range 6Ð7. These findings testify to involvement of the neutral purine molecule, and not its monoanion, as the substrate in the reverse, synthetic reaction. It is proposed that, in the reverse reaction pathway, the natural purine substrate is bound to the enzyme as the neutral N(7)H tautomer, which is responsible for the reported strong fluorescence of the guanine-PNP complex.
Introduction
Purine nucleoside phosphorylase (PNP, E. C. 2.4.2.1.), a ubiquitous enzyme of the purine salvage metabolic pathway, catalyses the reversible phosphorolysis of purine nucleosides, such as inosine and guanosine, and their 2Ј-deoxy analogues in eukaryotes and additionally (deoxy)adenosine in some prokaryotes, e.g. E. coli, as follows:
-(deoxy)nucleoside + P i < purine + α-(deoxy) ribose-1-phosphate Mammalian forms of PNP, particularly those of human and bovine origin, have been subjected to extensive structural and kinetic analyses (see Bzowska et al., 2000, and Pugmire and Ealick, 2002 for recent reviews), and the reaction mechanism has been partially elucidated. On the basis of structural (Erion et al., 1997; Mao et al., 1998) and kinetic isotope effect studies (Kline and Schramm, 0939Ð5075/2004/0900Ð0713 $ 06.00 " 2004 Verlag der Zeitschrift für Naturforschung, Tübingen · http://www.znaturforsch.com · D 1995), an oxocarbenium ionic structure of the ribose ring has been proposed for the transition state of the reaction, leading to the development of stable transition state analogues, viz. the iminoribitol C-nucleosides, referred to as immucillins (Miles et al., 1998; Schramm, 2002; Lewandowicz et al., 2003) , which are to date the best PNP inhibitors known, exhibiting promising pharmacokinetic properties (Kicska et al., 2002a) . Uncertainty, however, still exists as regards the extent to which the catalytic process of phosphorolysis resembles the well-known acid-catalyzed hydrolysis, i.e., if the process depends on prior nucleoside protonation on the imidazole ring N(7). At least three different mechanistic models have been proposed: Erion et al. (1997) , on the basis of site-directed mutagenesis and X-ray crystallography, concluded that no protonation of the purine N(7) occurs, and that the purine ring is negatively charged in the transition state, stabilized by a strong hydrogen bond to an asparagine amide (Asn243 in the human enzyme). As a consequence, in the reverse (synthetic) process, the purine base must be bound to the enzyme as an anion, with a negative charge on the imidazole ring. Schramm and coworkers (Fedorov et al., 2001) proposed that, despite the apparent absence of the appropriate acidic aminoacid residue in mammalian forms of PNP, protonation of N (7) can be attained with participation of an activated structural water molecule, thanks to the increased basicity of the nucleoside N(7) when approaching the transition state (cf. Kicska et al., 2002b) . This model requires that, in the reverse process, the purine ring must be bound to the enzyme as the neutral N(7)H tautomer. Subsequently, Tebbe et al. (1999) modified the Erion model, by postulating a transition state with a negative charge localized on the exocyclic O 6 of the purine moiety, followed by proton transfer from ribose-phosphate to the imidazole ring of the purine base, thus leading to release of a neutral purine molecule.
Although a number of binary PNP-purine and PNP-purine nucleoside complexes have been analyzed by X-ray crystallography (see Bzowska et al., 2000; Pugmire and Ealick, 2002) , the resolution attained is inadequate to identify protons. A more recent NMR study of immucillin-PNP complexes (Sauve et al., 2003; Deng et al., 2004) , although directly confirming protonation of the iminoribitol N(4Ј) and the ring N(7) of the immucillin H in the complex, also do not conclusively resolve this problem, since the pyrrolo proton of immucillin is clearly less acidic (pK a > 11, cf. Sauve et al., 2003) than the corresponding purine N(7)H or guanine N(1)H, and has no possibility to tautomerize. It is therefore desirable to directly identify ionic or tautomeric forms of purine substrates and substrate analogues bound to the enzyme.
We have previously demonstrated, in one favorable instance, that the tautomeric form of a bound nucleoside analogue inhibitor of the E. coli enzyme (formycin A, a structural analogue of adenosine, and its N 6 -methyl derivative) could be identified by means of fluorescence spectroscopy (Kierdaszuk et al., 2000) . We here apply similar techniques to analyze complexes of calf spleen PNP with 8-azaguanine, an excellent fluorescent substrate for the reverse synthetic pathway of the reaction (Wierzchowski et al., 1996 , and its 9-(2-phosphonylmethoxyethyl) derivative (Holý et al., 1996) , a bisubstrate analogue inhibitor (Kulikowska et al., 1998; and a putative transition state analogue for this reaction.
Experimental

Enzyme
Trimeric calf spleen PNP was a product from Sigma (St. Louis, MO, USA). The enzyme was desalted by centrifugation, using HEPES (N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid) buffer as described by Bzowska (2002) . Activities of the enzyme preparation were assayed by the standard method (Bzowska et al., 2000) and/or by 7-methylguanosine phosphorolysis at pH 7.0 (Kulikowska et al., 1986) . The enzyme concentration was determined from its absorbance at 280 nm, with a molar extinction per monomer of 28.9 · 10 3 m Bzowska, 2002) . Unless otherwise indicated, enzyme concentrations refer to monomer molarity.
Chemicals
8-Azaguanosine (8-azaGuo) was synthesized enzymatically, as previously described (Wierzchowski et al., 1996) . 9-(2-Phosphonylmethoxyethyl)-8-azaguanine (PME-azaG), synthesized by Holý et al. (1996) , was previously reported as an inhibitor of PNP (Kulikowska et al., 1998; Wielgus-Kutrowska et al., 2003) . Ribose-1-phosphate (R1P), 7-methylguanosine (m 7 Guo), and 8-azaG were products from Sigma. The latter was re-crystallized from water as the monosodium salt. All other chemicals were of the highest purity available. Water was filtered through a Milli-Q system (Millipore Corp., USA). Concentrations of stock solutions of substrates, inhibitors and standards, except R1P, were determined spectrophotometrically, using molar extinctions listed in Table I .
Instrumentation
Spectrophotometric measurements were carried out with Kontron (Austria) Uvikon-922, Uvikon-930 or Shimadzu UV-1601PC instruments, equipped with thermostatic units. Fluorescence was measured with a Shimadzu RF-5001PC or a Perkin-Elmer LS-50B spectrofluorimeter (Norwalk, CT, USA), both with thermostatically-controlled cell compartments. Spectral bandwidths were 2Ð 5 nm for the entrance slit, and 3Ð15 nm for the exit slit.
Enzyme kinetics
Phosphorolysis of m 7 Guo was followed spectrophotometrically at 260 nm (Kulikowska et al., 1986) . Rates of enzymatic synthesis of 8-azaGuo were measured either spectrophotometrically, with observation at 260 nm and ∆ε determined at each pH (6.5 · 10 3 m Ð1 cm Ð1 at pH 7.0), or fluorimetrically, using the purified product (8-azaGuo) as an internal standard . In the latter case the reaction rates were calculated according to the formula:
where dF/dt is the fluorescence change with time, F st the fluorescence of the standard, c st the concentration of the standard. For kinetic measurements employing high substrate concentrations, corrections for the inner-filter effect were introduced, by multiplying the resultant rates by 10
, where A is the absorbance of the sample at the excitation wavelength, as determined spectrophotometrically prior to fluorimetric measurements. At pH < 6.5, where 8-azaGuo is virtually nonfluorescent, the synthetic reaction was followed by the decrease in fluorescence of the neutral form of the substrate (8-azaG) at 420 nm with excitation at 315 nm, the initial fluorescence signal serving as an internal standard for rate calculations. All assays and kinetic measurements were carried out at 25 ∞C.
Kinetic parameters were calculated with the use of linear multiple regression analysis, by fitting the initial rate data to the generalized kinetic equation for a bisubstrate enzymatic reaction in the form (Segel, 1975) : Inhibition of the enzyme by the bisubstrate analogue inhibitor PME-azaG was analyzed assuming a double competitive model (i.e., assuming only a binary enzyme-inhibitor complex):
where [I] is the inhibitor concentration and K i the inhibition constant. With one of the substrates (S 2 ) at constant concentration, it is possible to determine the apparent inhibition constants, K i app , by measuring initial rates with varying concentrations of the second substrate (S 1 ) and the inhibitor. The thermodynamic value of the inhibition constant K i is related to K i app by:
Fluorimetric titrations
Fluorimetric titrations were performed in 1-ml semi-micro cuvettes with a 4-mm pathlength in the excitation beam. In some experiments, enzyme concentration was kept constant during titration (i.e., the titrant additionally contained protein at a concentration equal to that in the titrated sample). Otherwise, corrections for enzyme dilution were introduced. Fluorescence intensity was always corrected for the inner-filter effect.
Titration curves, F(X), where X is the total ligand concentration, were fitted nonlinearly to a single binding site model, which leads to the following equation (Kierdaszuk et al., 2000) :
where K d is the dissociation constant, E the concentration of binding sites, F 0 , F L and F p are the fluorescence intensities of free protein, free ligand and protein-ligand complex, respectively. When results are expressed in terms of difference spectra (FÐF sum ), the titration curves are expressed as:
and for those cases where E << X, the above equation is simplified to (Kierdaszuk et al., 2000) :
Results and Discussion
Spectral properties of 8-azaG, PME-azaG and 8-azaGuo
Spectral properties of 8-azaG and 8-azaGuo, reported previously (Wierzchowski et al., 1996) , are summarized in Table I and Fig. 1 , and compared to those of PME-azaG. It is evident that UV and fluorescence spectra of the PME-azaG fluorophore with either the neutral or monoanionic form of the base moiety (cf. Fig. 2 ) are virtually identical to the corresponding spectra of 8-azaGuo, but quite distinct from those of 8-azaG. In general, the monoanionic forms of these two compounds are highly fluorescent, while their neutral forms emit only weakly. The reverse holds for 8-azaG (Table  I ). The higher pK a for deprotonation of PMEazaG relative to 8-azaGuo (9.0 vs. 8.0) is ascribed to electrostatic interactions with the ionized phosphonate group (pK a Ϸ 7.7). For both compounds pK a values determined spectrophotometrically were in good agreement with those obtained from fluorimetric titrations.
These striking differences in spectral properties between 8-azaG and its nucleoside are attributed to structural differences between their neutral, as well as their monoanionic forms. As demonstrated previously (Wierzchowski et al., 1996) , neutral 8-azaG exists as a mixture of at least two tautomeric forms, one of which, minor, exhibits intense fluorescence at 395 nm, while the dominant N(9)H form is virtually nonfluorescent, leading to striking differences between the UV absorption and fluorescence excitation spectra (see Fig. 1a ). The fluorescent tautomer has been tentatively identified as N(8)H, albeit minor participation of the N(7)H form cannot be excluded. This tautomerism is not Table I . Spectral parameters for neutral and monoanionic forms of 8-azaG, 8-azaGuo, and PME-azaG. Data from Albert (1986) , Wierzchowski et al. (1996 , Holý et al. (1996) , and present work. (Wierzchowski et al., 1996) . Other o | values are virtually independent of λ exc . possible in the nucleoside, nor in the 9-alkoxyphosphonate derivative.
The difference between the monoanion structures of 8-azaG and 8-azaGuo is a consequence of the high acidity of the triazole proton in the former compound, generally true for 8-azapurines (Albert, 1986) . While the monoanion of 8-azaGuo (pK a 8.0) resembles that of Guo, i.e., it results form dissociation of the N(1)H, the parent base, 8-azaG, tends to lose the more acidic triazole proton (pK a 6.5), as shown in Scheme 1. This conclusion is supported by comparison of the pK a values for proton dissociation of the N-methyl derivatives of 8-azaG which, for the N(9), N(8) and N(7) methyl congeners, are in the range 8.0Ð 8.65 (Albert, 1986; Wierzchowski et al., 1996) , i.e., Fig. 1 . Spectral properties of the neutral form of 8-azaG at pH 4.5 (upper frame) and of the monoanion at pH 8.9 (lower frame): (444) absorption spectra, 100 µm; (Ð Ð Ð) emission specta with λ exc = 290 nm; (șșșșș) fluorescence excitation spectra, corrected and normalized to the absorption spectra. Since pK a values for proton dissociation for 8-azaG and 8-azaGuo differ by only 1.5 units, it is plausible that a small proportion (~3%) of the "classic" structure N(9)H, i.e. resulting from dissociation of the N(1)H, may be present in the 8-azaG monoanion. We have examined the fluorescence excitation spectrum of 8-azaG at pH~9 and found that it differs significantly from the UV absorption spectrum (cf. Fig. 1b , note especially the absence of the second maximum at~245 nm in the excitation spectrum), but fits very well to both the UV absorption and fluorescence excitation spectra of 8-azaGuo (or PME-azaG, see Fig. 2 ) monoanion. It is therefore very likely that the observed weak emission of the 8-azaG monoanion at pH 9, centered at 355 nm (see Table I ), originates from the minor N(9)H structure, while the principal N(1)H form, with negative charge localized on the triazole ring, must be regarded as virtually nonfluorescent.
8-azaG and 8-azaGuo as fluorescent/fluorogenic substrates for calf spleen PNP
8-azaG, a fluorescent analogue of guanine, has been previously shown to be a good and, in some conditions (pH > 7), a highly fluorogenic substrate for the calf spleen, as well as the human PNP in the reverse synthetic pathway .
We have reevaluated kinetic parameters for this reaction at various pH values, using desalted enzyme (Bzowska, 2002) and phosphate-free buffers. The fluorimetric method was used to determine initial velocities and spectrophotometric measurements to check the reaction rates at various pH. The initial velocity data were fitted to the generalized kinetic equation (eqn. {1}, see Experimental), using multiple regression. The resulting kinetic parameters (K m1 , K m2 , K 12 and V max ), obtained using the UV and/or fluorimetric methods, are shown in Table II. The observed strong pH-dependence of K m , but not V max , suggests that only the neutral form of 8-azaG (pK a 6.5) is a substrate in the synthetic reaction. This is in qualitative agreement with previous, preliminary data (Wierzchowski et al., 1996) , as well as with a more detailed analysis of the human en- zyme . There is also apparently no synergistic interaction between binding sites for both substrates, since K 12 Ϸ K m1 · K m2 , especially pronounced at pH 7 to 8.
Reversibility of the reaction and equilibrium constant
The enzymatic synthesis of 8-azaGuo, previously regarded as virtually irreversible (Wierzchowski et al., 1996) , is, in fact, reversible, but its estimated equilibrium constant, K eq~3 20, is highly in favor of nucleoside synthesis compared to the natural purines (K eq~5 5). We have also noted that the phosphorolysis of 8-azaGuo with calf PNP is about 150-fold slower than for guanosine, and under standard experimental conditions employed for PNP kinetics it is barely detectable. The K m value for 8-azaGuo phosphorolysis in 50 mm phosphate buffer, pH 7.0, was found to be~55 µm (data not shown), of the same order of magnitude as that for guanosine (~13 µm).
Inhibition of PNP by PME-azaG
Some 9-alkoxyphosphonoethyl purines and purine analogues, previously examined as PNP inhibitors in the phosphorolytic pathway (Kulikowska et al., 1998; WielgusKutrowska et al., 2003) , exhibited competition with both nucleoside and phosphate substrates (Kulikowska et al., 1998) . We now present a more detailed analysis of PME-azaG as an inhibitor of both the phosphorolytic and synthetic pathway.
In the phosphorolytic pathway, the substrate employed was N(7)-methylguanosine (m 7 Guo) which, in striking contrast to Ino and Guo, fairly well follows Michaelis-Menten kinetics (Bzowska, 2002) . With fixed concentrations of one substrate (nucleoside or phosphate), apparent inhibition constants (K i app ) were calculated from initial velocity data with variable concentrations of the inhibitor and the second substrate. Dixon plots displayed a competitive mode of inhibition (not shown), but the apparent K i values were dependent on the fixed substrate concentration (cf. Guo (disagreement by a factor of 13) and ca. 0.01Ð0.02 for phosphate (Kulikowska et al., 1986; Bzowska, 2002) . Thus, the apparent inhibition constants are somewhat less sensitive to the m 7 Guo concentration, i.e., at nearly saturating levels of m 7 Guo, K i app values remain close to the thermodynamic K i value. We conclude that inhibition of the phosphorolytic reaction by PME-azaG, with K i = 0.8 ð 0.2 µm at pH 7, is not strictly represented by the competitive model of inhibition, based on Michaelis-Menten kinetics. The marked increase in K i at pH 8 (data not shown), is clearly due to the effect of secondary phosphonate ionization, bearing in mind that the pK a of benzyl phosphonate is 7.7.
In turn, we examined the inhibition of the reverse synthetic reaction by PME-azaG, with 8-azaG and ribose-1-phosphate (R1P) as substrates in phosphate-free HEPES buffer, pH 7. As for the phosphorolytic pathway, an apparently competitive type of inhibition was observed (data not shown), and the K i app values were markedly dependent on the second (fixed) substrate concen- 
Binary complex between PNP and 8-azaG
Guanine forms a tightly bound (K d < 1 µm), and highly fluorescent complex with calf spleen PNP in phosphate-free media (Porter, 1992; Bzowska, 2002) . The origin of this fluorescence, initially ascribed to formation of the guanine monoanion upon binding (Porter, 1992) , is difficult to interpret, since fluorescence of the complex, centered at~330 nm, coincides with the protein emission. We therefore attempted to characterize the analogous complex with the fluorescent 8-azaG. Best results were obtained with excitation at 310Ð 315 nm, where both protein and ligand have relatively weak absorbances. At pH 7 and with ligand concentrations of~100 µm, a relatively strongly fluorescent complex can be observed, with fluorescence emission centered at 370 nm, resembling somewhat that of neutral 8-azaG (395 nm), but with at least a 20-fold higher intensity (cf. Fig. 4) . A titration curve (Fig. 4, right panel) , analyzed using the standard equation for single-site binding (equation {6}, see Experimental), led to an association constant of 90 ð 5 µm, a value close to the K m obtained from kinetic measurements (cf .  Table II) . Similar results were obtained at pH 7.7, but the fitted association constant was higher, 450 µm (not shown), again in line with kinetic data. Thus, K d for the complex between 8-azaG and PNP is at least 2 orders of magnitude higher than for the analogous guanine/PNP complex.
With excitation at 290 nm and after subtracting the spectrum of the free ligand (Fig. 4) , both protein and bound ligand emission can be observed separately at 320Ð330 and 370 nm, respectively. Under these conditions, protein fluorescence is virtually unchanged during titration (see Fig. 4 ), in apparent contrast to the guanine/PNP binary complex (Porter, 1992) , but resembling our previous data on PNP complexes with alkoxyphosphonate derivatives of guanine . Taken together, these data give further credence to our interpretation of the fluorescence enhancement in the guanine/PNP complex (Porter, 1992) as originating from the purine moiety (possibly in an ionic and/or non-typical tautomeric form, cf. Wielgus- Kutrowska et al., 2002) , and not from protein tryptophan.
The increase of 8-azaG fluorescence upon binding PNP and its shift from 395 to 370 nm can be interpreted either in terms of fluorescence enhancement upon binding or as the effect of a tautomeric shift, as previously found for tautomerizable nucleoside analogue inhibitors bound to E. coli PNP (Kierdaszuk et al., 2000) . Comparison of the fluorescence of the 8-azaG/PNP complex with that of free 8-azaG at pH 8.9 (Table I, Fig. 1 ) strongly suggests that this emission is unlikely to originate from the fluorescent 8-azaG anion, which emits at 355 nm in aqueous medium, since this would imply an increase of the Stokes' shift by 15 nm in the complex, contrary to the usual decrease in the Stokes' shift observed for fluorescent ligands upon binding to the PNP active site (Wierzchowski et al., 1999, and unpublished data) . For the same reason the principal N(9)-H tautomer of neutral 8-azaG, which emits at~350 nm, is excluded (cf. Table I and Fig 2) . Hence the most likely source of the strong emission of the complex at 370 nm is the neutral N(8)H or/and N(7)H tautomer of 8-azaG.
The difference UV absorption spectrum, recorded during titration, is close to a "mirror image" spectrum of the neutral to anion transition ( Fig. 5) . Bearing in mind that, at pH 7, 8-azaG is largely (~70%) in the anionic form, this result additionally supports the proposal that the ligand is bound in its neutral form, with a possible tautomeric shift towards the strongly fluorescent N(7)H or/and N(8)H forms. ) UV difference spectrum, in 20 mm HEPES, pH 7, between calf spleen PNP (13.9 µm) + 8-azaG (67 µm) and the sum of the two constituents; (Ð Ð Ð Ð Ð Ð Ð Ð Ð) calculated difference spectrum between the anionic and neutral forms of 8-azaG (13.9 µm). Note the approximate mirror images of the two curves.
Taken together, both the kinetic and spectral data argue against binding of anionic 8-azaG as the starting point in the reverse synthetic reaction of PNP, as postulated by Erion et al. (1997) for natural purines. It should be noted, in this context, that the anionic form postulated in Erion's mecha-nism (i.e., deprotonation of the imidazole ring) does not correspond to the predominant anionic form of guanine or hypoxanthine, involving dissociation of the N(1)-H (Shugar and Psoda, 1991), but does correspond to that of the 8-azaG anion, resulting from dissociation of the triazole proton (Scheme 1; cf. Albert, 1986) . If binding of this anionic species is really the starting point of the reaction, one would expect its strong association to the enzyme, which is not the case. Thus, the observed relatively weak binding of 8-azaG and no evidence for an anionic structure in its complex with PNP argue against the Erion model and is in favor of a model involving the neutral purine species as the substrate in the synthetic pathway.
Binary complex between PNP and PME-azaG
Desalted calf spleen PNP, 3Ð11 µm, was titrated with the title compound at pH 7 and 5.9, with excitation at 290 nm or 305 nm. Spectral effects of titration and a typical titration curve are given in Fig. 6 . Fluorescence difference spectra reveal in all cases a fairly strong complex, emitting at 340 nm, i.e., clearly different from that obtained for the PNP complex with 8-azaG (~370 nm, see Fig. 3 ). This is because PME-azaG (as well as 8-azaGuo) does not display a ring prototropic tautomerism, thus spectrally resembling the principal N(9)H form of 8-azaG.
Nonlinear fitting of the titration curve to equation {5} (see Experimental) revealed essentially a single binding site and an association constant, K d Ϸ 0.4 µm at pH 5.9 and 0.55 µm at pH 7, slightly lower than that previously reported , possibly due to better desalting of the enzyme. This value is somewhat lower than the inhibition constant, K i (see above), suggesting that the assumed one-site model of inhibitor binding and/or the Michaelis-Menten kinetic model may not be strictly applicable. The stoichiometry of complexes of PNP with purine alkoxyphosphonates has been the subject of some uncertainty Bzowska, 2002) . On the basis of titration curves, we previously postulated a 1:3 (or one per trimer) stoichiometry , similar to that reported for transition-state analogues (Miles et al., 1998) . Some doubts remain, however, as to whether enzyme concentration, determined from UV absorption at 280 nm, corresponds strictly to the active site concentration. Different enzyme preparations do not give fully reproducible results, undoubtedly related to the fact that their specific activities differ markedly from the reported maximum value of 34 U/mg (Bzowska et al., 2000) . In the present case, with a specific activity of the enzyme of 14 U/mg, an apparent stoichiometry close to 1:2 was obtained. We therefore conclude that the most likely stoichiometry of the PME-azaG/PNP complex is 1:1 (i.e. three molecules of inhibitor per trimeric enzyme; cf. Bzowska, 2002; Iwanow et al., 2003) .
Fluorescence difference spectra, obtained during titration, may be compared to the fluorescence of an equimolar amount of the neutral and anionic forms of the ligand (cf. Fig. 2 and 6 ). This points tõ 10-fold increase of the ligand fluorescence upon binding to PNP, assuming that it remains in its neutral form. By contrast, the free anionic form of the ligand is~40-fold more fluorescent than its neutral form (cf. Table I and Fig. 2) , and 4-to 5-fold more fluorescent than the complex (not shown). Since quenching of ligand fluorescence is not observed upon association of any purine analogue with calf spleen PNP Wielgus-Kutrowska et al., 2003, and unpublished data) , we conclude that, in the complex, the ligand cannot be ionized, but rather that enhancement of the emission of the neutral species (i.e. that observed in the pH range 4Ð7) is observed. This conclusion is supported by the UV difference spectrum recorded during titration (cf. Fig. 7 ), which clearly does not resemble the difference between the neutral and anionic species of PMEazaG.
In light of the foregoing, the proposed structure of the fluorescent complex of calf spleen PNP with guanine requires re-interpretation. The strong increase in emission observed in this complex (λ max~3 30 nm), ascribed to the anion of Gua by Porter (1992) , may originate from the N(7)H neutral tautomer (cf. Wielgus-Kutrowska et al., 2002) . This tautomer was long ago shown to fluoresce DAbsorbance Fig. 7 . ( ) UV difference spectrum in 20 mm acetate buffer, pH 5.9, between calf spleen PNP (11.9 µm) + 25.44 µm PME-azaG and the sum of the two; (----) calculated difference spectrum between the anionic and neutral forms of PME-azaG (11.9 µm). The terms "anionic" and "neutral" refer to the fluorophore only, and not to the phosphonate moiety. strongly in rigid glasses at 140Ð160 K, with o |~0.7 and λ max~3 25 nm, while the predominant N(9)H form exhibits no fluorescence even under these highly favorable conditions (Wilson and Callis, 1980) . Although guanine and N 7 -methylguanine do not emit in neutral aqueous medium at room temperature (o | < 10 Ð3 ), the reported very strong binding of purines by PNP in the absence of phosphate (Kline and Schramm, 1992; Bzowska et al., 2000; Bzowska, 2002 ) may lead to increased rigidity in the complex, resulting in an enhanced fluorescence yield of the bound neutral N(7)H form, as observed for other weakly fluorescent ligands on binding WielgusKutrowska et al., 2003) .
The foregoing supports the Schramm model of the reaction, postulating protonation of the purine ring N(7) as the initial step in nucleoside phosphorolysis (Kline and Schramm, 1995) , subsequently also proposed for E. coli PNP, where the essential Asp204 residue is presumed to be responsible for nucleoside N(7) protonation in the transition state Bennett et al., 2003) . The situation is less clear for mammalian PNPs, where the acidic Glu201, presumably in the anionic state, is located close to the nucleoside N(1)H, and N (7) is bound either to Asn243 or to a structural water molecule (Fedorov et al., 2001) . Our results suggest that, in the transition state, the N(7) may be protonated, as it is at the reaction endpoint, although the pathway to this protonation remains unresolved.
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